Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis

Ross, L; Lindqvist, A; Costello, B; Hansen, D; Brown, Z; Day, JA; Stevens, W; Burns, A; Perera, W; Pianta, M; La Gerche, A; Nikpour, M

Author(s): Ross, L; Lindqvist, A; Costello, B; Hansen, D; Brown, Z; Day, JA; Stevens, W; Burns, A; Perera, W; Pianta, M; La Gerche, A; Nikpour, M;
Details: Publication Year 2022-04-11,Volume 24,Issue #1,Page 84
Journal Title: Arthritis Research & Therapy
Abstract: BACKGROUND: Skeletal muscle can be directly affected by systemic sclerosis (SSc); however, a significant burden of SSc-associated myopathy is undetected because clinical parameters such as weakness and creatine kinase (CK) are unreliable biomarkers of muscle involvement. This study presents qualitative and quantitative magnetic resonance imaging (MRI) findings that quantify the prevalence of myopathy and evaluate any association between skeletal and cardiac muscle involvement in SSc. METHODS: Thirty-two patients with SSc who fulfilled the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria underwent skeletal muscle MRI in addition to cardiac MRI. Skeletal muscles were independently assessed by two musculoskeletal radiologists for evidence of oedema, fatty infiltration and atrophy. Skeletal muscle T2 mapping times and percentage fat fraction were calculated. Linear regression analysis was used to evaluate the clinical and myocardial associations with skeletal muscle oedema and fatty infiltration. Cardiac MRI was performed using post gadolinium contrast imaging and parametric mapping techniques to assess focal and diffuse myocardial fibrosis. RESULTS: Thirteen participants (40.6%) had MRI evidence of skeletal muscle oedema. Five (15.6%) participants had fatty infiltration. There was no association between skeletal muscle oedema and muscle strength, creatine kinase, inflammatory markers or fibroinflammatory myocardial disease. Patients with skeletal muscle oedema had higher T2-mapping times; there was a significant association between subjective assessments of muscle oedema and T2-mapping time (coef 2.46, p = 0.02) and percentage fat fraction (coef 3.41, p = 0.02). Diffuse myocardial fibrosis was a near-universal finding, and one third of patients had focal myocardial fibrosis. There was no association between skeletal myopathy detected by MRI and burden of myocardial disease. CONCLUSIONS: MRI is a sensitive measure of muscle oedema and systematic assessment of SSc patients using MRI shows that myopathy is highly prevalent, even in patients without symptoms or other signs of muscle involvement. Similarly, cardiac fibrosis is highly prevalent but occurs independently of skeletal muscle changes. These results indicate that novel quantitative MRI techniques may be useful for assessing sub-clinical skeletal muscle disease in SSc.
Publisher: BMC
Research Division(s): Inflammation
PubMed ID: 35410246
Publisher's Version: https://doi.org/10.1186/s13075-022-02768-z
Open Access at Publisher's Site: https://doi.org/10.1186/s13075-022-02768-z.
Terms of Use/Rights Notice: Refer to copyright notice on published article.
Documents: Ross et al_Arthritis Res Ther_2022.pdf - (0.91MB, application/pdf)

Creation Date: 2022-04-14 08:35:35

Last Modified: 2022-04-14 08:39:58